CRVL vs EW · P/E 29, rev $958.5M vs P/E 47, rev $3.39B
CorVel Corp (CRVL) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
CorVel Corp (CRVL) is a insurance brokers company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CRVL revenue for 2026-03-31 was $958.5M. Net income was $110.3M. Revenue was up 7.0% from 2025-03-31 to 2026-03-31. CRVL currently screens at market cap $3.13B and trailing P/E 28.9.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CRVL currently screens at market cap $3.13B and trailing P/E 28.9. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CRVL and EW stock pages for the full models.
Not investment advice.